Loading...
XSHG
688131
, Last price  
Name

Shanghai Haoyuan Chemexpress Co Ltd

Chart & performance

D1W1MN
XSHG:688131 chart
P/E
—
P/S
—
EPS
2.24
Vol. 1Y
—
Shs. 5Y
6.69%
Rev. 5Y
35.16%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.87b
+26.20%
58,623,48267,087,32391,932,934117,081,018173,966,702300,195,128408,969,004635,100,714969,225,5591,358,053,9741,880,046,7682,270,177,8112,865,010,784
Net income
240m
+18.96%
2,324,4113,151,2078,535,79418,020,38015,006,92718,414,16573,429,634128,433,262190,979,587193,643,503127,449,122201,590,096239,806,806
CFO
330m
-13.67%
1,189,880-3,963,1831,819,872-12,193,15810,629,06528,427,63957,071,168116,789,31957,834,5530-62,265,030381,960,258329,738,892
Dividend
Sep 21, 20260.09 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Haoyuan Chemexpress Co., Ltd. is dedicated to the innovation and advancement of key compounds for the pharmaceutical industry, focusing on small molecule drugs and their essential intermediates. The company's production capabilities encompass active pharmaceutical ingredients (APIs) and their precursors, various vitamin D series substances, as well as specialized chemical building blocks and life science compounds tailored for contract research organizations (CROs). Established in 2006, its primary operational base is located in Shanghai, China.
IPO date
Jun 08, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT